NAM Atiqur Rahman (PhD)
NAM Atiqur Rahman, Ph.D., is the Director of the Division of Cancer Pharmacology II within the Office of Clinical Pharmacology (OCP), OTS, CDER, US Food and Drug Administration (USFDA). The Division includes clinical pharmacology reviewers who are involved in the development, review, approval, and life cycle management of the drugs and therapeutic biologics for solid tumors. Prior to 2020, Dr. Rahman led the Division of Clinical Pharmacology V in charge of ushering the application of clinical pharmacology in the development, approval and post-marketing assessments of both solid tumors and hematologic malignancies.
Dr. Rahman is involved in various outreach programs organized by the Oncology Center of Excellence and by the Office of Clinical Pharmacology. He is also responsible for the development of guidances, development and application of policies, leading internal initiatives, and development and training of clinical pharmacology reviewers.